Where do Cytokinetics's ratios come from?

Every ratio is computed from Cytokinetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Cytokinetics CYTK Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-695.4%+2,207pp	-2,902.7%+3,687pp	-6,589.7%-6,247pp	-342.8%-78.2pp
Net margin	-891.6%+2,300pp	-3,191.1%+3,798pp	-6,988.6%-6,577pp	-411.2%-105pp
EBITDA margin	-683.9%+2,167pp	-2,851.1%+3,581pp	-6,431.8%-6,095pp	-336.6%-75.3pp
Free cash flow margin	-607.5%+1,557pp	-2,164.1%+3,357pp	-5,521.2%-5,193pp	-328.6%-56.9pp
Returns
Return on assets	-55.5%-2.6pp	-53%+4.3pp	-57.2%-15.3pp	-41.9%-10.6pp
Efficiency
Asset turnover	0.1×0.0×	0×0.0×	0×-0.1×	0.1×0.0×
Liquidity
Current ratio	4.5×-1.6×	6.2×0.0×	6.1×-3.3×	9.4×+1.9×
Quick ratio	4.5×-1.6×	6.2×0.0×	6.1×-3.3×	9.4×+1.9×
Cash ratio	0.6×+0.1×	0.5×-0.6×	1.1×+0.3×	0.8×-0.8×
Leverage
Debt-to-assets	0.3×+0.1×	0.2×-0.1×	0.3×0.0×	0.2×0.0×
Interest coverage	-13.4×+0.8×	-14.2×+3.3×	-17.5×-0.8×	-16.7×-5.4×
Per Share
Book value per share	-$5.49-354%	-$1.21+69.8%	-$4.00-233%	-$1.20-138%
Valuation
Market capitalization	$7.77B+39.9%	$5.55B-32.2%	$8.19B+88.8%	$4.34B+12.7%
Enterprise value	$8.06B+41.6%	$5.69B-31.3%	$8.28B+85.0%	$4.48B+14.5%
Price / sales	88.2×-212×	300.5×-787×	1,087.2×+1,041×	45.8×-8.8×
EV / sales	91.6×-217×	308.2×-792×	1,099.8×+1,052×	47.3×-8.2×
Free cash flow yield	-6.9%+0.3pp	-7.2%-2.1pp	-5.1%+2.1pp	-7.2%-2.2pp
Earnings yield	-10.1%+0.5pp	-10.6%-4.2pp	-6.4%+2.5pp	-9%-3.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Cytokinetics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Cytokinetics's ratios come from?: Every ratio is computed from Cytokinetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.